PRIMECAP MANAGEMENT CO/CA/PRIMECAP MANAGEMENT CO/CA/

Institutional investor · Portfolio as of Q4 2018

Top Holdings291 positions

Checking export access…
Activity:

ELI LILLY & CO

50.6M$5.9B4.7%$104.770.00%
1 qtr
First report
0

ADOBE INC

19.8M$4.5B3.6%$226.240.00%
1 qtr
First report
0

BIOGEN INC

14.7M$4.4B3.6%$300.920.00%
1 qtr
First report
0

MICROSOFT CORP

38.7M$3.9B3.2%$94.430.00%
1 qtr
First report
0

AMGEN INC

19.8M$3.9B3.1%$153.910.00%
1 qtr
First report
0

SOUTHWEST AIRLS CO

73.8M$3.4B2.8%$41.940.00%
1 qtr
First report
0

UNITED AIRLS HLDGS INC

38.3M$3.2B2.6%$83.730.00%
1 qtr
First report
0

TEXAS INSTRS INC

33.6M$3.2B2.6%$76.190.00%
1 qtr
First report
0

FEDEX CORP

15.1M$2.4B2.0%$113.180.00%
1 qtr
First report
0

ALPHABET INC

2.2M$2.3B1.9%$51.760.00%
1 qtr
First report
0

JPMORGAN CHASE & CO

23.2M$2.3B1.8%$78.710.00%
1 qtr
First report
0

AMERICAN AIRLINES GROUP INC

68.9M$2.2B1.8%$31.600.00%
1 qtr
First report
0

ALPHABET INC

2.1M$2.2B1.8%$51.290.00%
1 qtr
First report
0
AZNAZN
ADR

ASTRAZENECA PLC

56.1M$2.1B1.7%$63.100.00%
1 qtr
First report
0

NETAPP INC

35.4M$2.1B1.7%$48.510.00%
1 qtr
First report
0

WELLS FARGO & CO

45.5M$2.1B1.7%$37.340.00%
1 qtr
First report
0
BABABABA
ADR

ALIBABA GROUP HLDG LTD

15.3M$2.1B1.7%$128.990.00%
1 qtr
First report
0
SONYSONY
ADR

SONY GROUP CORP - SP ADR

41.8M$2B1.6%$9.260.00%
1 qtr
First report
0
NVSNVS
ADR

Novartis AG ADR

22.9M$2B1.6%$57.300.00%
1 qtr
First report
0
7.7M$1.9B1.5%$98.98—
1 qtr
First report
0
$123.4B
AUM
291
Positions
Q4 2018
Filing
HI score · 3.5/5
Quarterly 13F Value Change
Not enough history yet
Activity profile
Q4'18

First report: nothing earlier to compare

Composition
Equity vs derivatives
Equity100%Puts0%Calls0%
Holding period
<1Q100%1-4Q0%1-2Y0%2Y+0%

PRIMECAP MANAGEMENT CO/CA/ manages $123.4B across 291 positions as of Q4 2018. Top holdings: LLY (4.7%), ADBE (3.6%), BIIB (3.6%). Fund DNA: Steady Compounder. HoldingsIntel Score: 3.5/5.0.

Q4 2018 Summary

First quarter we have for this fund: 291 positions, nothing earlier to compare. No standout high-conviction moves this quarter. Portfolio: $123.4B across 291 positions.

Top holdings by portfolio weight

Total AUM$123B
LLY4.74%
ADBE3.64%
BIIB3.59%
MSFT3.18%
AMGN3.13%
LUV2.78%
UAL2.60%
TXN2.57%
FDX1.97%
GOOGL1.86%
Other1.83%

Portfolio allocation by GICS sector

Sectors11
Technology28.46%
Healthcare24.05%
Industrials15.19%
Unknown9.74%
Consumer Cyclical8.30%
Financial Services8.25%
Communication Services4.29%
Energy0.88%
Basic Materials0.45%
Consumer Defensive0.35%
Other0.04%

Behavioral investing profile

Checking access…
Steady Compounder- primarily Technology, Healthcare, Industrials
Compare DNA across all funds
7-dimension, SEC 13F-derived research score
Strong(3.5 / 5.0)
Holdings P&L68
Conviction36
Concentration64
Checking access…

Position Outcomes

Best and worst performing positions by estimated return

Cost basis estimates based on full filing history using quarter-end prices. Actual transaction prices are not disclosed in 13F filings.

Similar Funds

Funds with similar investing DNA

Accumulation Streaks

Positions with 2+ consecutive quarters of increases - persistent directional conviction.

Security
7Q
COPCOPCONOCOPHILLIPS
Q4 2024 → Q2 2026+7.3M shares+$749.8M
7Q
SCHWSCHWCHARLES SCHWAB
Q4 2024 → Q2 2026+24.1M shares+$2.3B
7Q
USFDUSFDUS FOODS HLDG CORP
Q4 2024 → Q2 2026+3.7M shares+$389.3M
Checking access…

Famous Investors' Portfolios

What the most-followed managers hold, and what they bought and sold each quarter.

Data sourced from SEC EDGAR 13F filings. Not financial advice. Full disclaimer

Verify source filings on SEC EDGAR

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used